de novo
ventures
"of new"
venture capital
BUILDING GREAT TECHNOLOGY COMPANIES
100%
All of our portfolio companies are thriving and growing
>4x
Return on investments
LATEST
INVESTMENTS
CAPSULASER
Selective laser capsulotomy
Enhancing sight
ALPHAEON CREDIT
Enhancing patient financing
MILO
The Action Communicator
Enhancing communication
OUR ETHOS
CUSTOMER
FOCUS
We never forget that our portfolio companies are here to serve their customers and always be guided by their moral compass.
PRIDE IN EXCELLENCE
We set a high bar and sweat the details. Holding ourselves accountable and always striving for excellence through continual improvement.
WINNING CULTURE
We support our companies until they succeed.
We are focused on:
winning products
+ winning teams
= winning results
PORTFOLIO
IPO(NASDAQ): EOLS
Acquired by Merz
OPTIMEDICA
PRECISIONLIGHT
Sold twice:
+ Cataract division acquired by Abbot now part of J&J Vision
+ Retina division acquired by Topcon
Acquired by Allegan
now part of Abbvie
OUR DNA
de novo ventures has a long history of world-class entrepreneur expertise. All the de novo team have built great companies as executive management, upon successful exit the CEOs and founders of our portfolio companies are invited to be part of de novo ventures. This brings real-world experience to creating the "next" great technology companies.
Dave Mordaunt PhD
Managing Director